“Enrollment shortages have delayed or canceled trials on experimental therapies. Researchers are trying to reverse that trend, in part by using databases to connect patients with possible new cures.
A year ago, U.S. researchers launched what they deemed a high-priority study to determine if women with an often-fatal type of breast cancer could live longer by taking a specific combination of drugs. If the study found that to be true, the average rate of survival — four years — could be significantly extended.”
Article
Shari Roan, Los Angeles Times, 14 March 2009
